4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0000905148-24-003223
President and CEO gave up 60,256 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Blume-Jensen Peter · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-14 | Shares withheld for taxes : show line 1 in the form | −59,766 | $7.92 | $473,347 | 2,362,747 | D |
| 2024-11-14 | Shares withheld for taxes : show line 2 in the form | −490 | $7.92 | $3,881 | 316,756 | I |
Loading xslF345X05/form4.xml…